Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.

Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N.

J Ethnopharmacol. 2012 Oct 11;143(3):755-71. doi: 10.1016/j.jep.2012.08.013. Epub 2012 Aug 21. Review.

PMID:
22940241
2.

Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.

Romiti N, Tramonti G, Corti A, Chieli E.

Phytomedicine. 2009 Dec;16(12):1095-100. doi: 10.1016/j.phymed.2009.05.001. Epub 2009 Jul 3.

PMID:
19577448
3.

What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.

Mncwangi NP, Viljoen AM, Zhao J, Vermaak I, Chen W, Khan I.

Phytochemistry. 2014 Oct;106:104-15. doi: 10.1016/j.phytochem.2014.06.012. Epub 2014 Jul 17.

PMID:
25041697
5.

Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.

Abdelouahab N, Heard C.

J Nat Prod. 2008 May;71(5):746-9. doi: 10.1021/np070204u. Epub 2008 Apr 16.

PMID:
18412394
6.
7.

Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).

Qi J, Chen JJ, Cheng ZH, Zhou JH, Yu BY, Qiu SX.

Phytochemistry. 2006 Jul;67(13):1372-7.

PMID:
16857222
8.

Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.

Abdelouahab N, Heard CM.

Planta Med. 2008 Apr;74(5):527-31. doi: 10.1055/s-2008-1074500. Epub 2008 Apr 10.

PMID:
18401847
9.

Harpagoside: from Kalahari Desert to pharmacy shelf.

Georgiev MI, Ivanovska N, Alipieva K, Dimitrova P, Verpoorte R.

Phytochemistry. 2013 Aug;92:8-15. doi: 10.1016/j.phytochem.2013.04.009. Epub 2013 May 1.

PMID:
23642455
10.

Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.

Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J, Loew D.

Phytomedicine. 2004 Nov;11(7-8):585-95.

PMID:
15636171
11.
12.
13.

The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.

Stewart KM, Cole D.

J Ethnopharmacol. 2005 Sep 14;100(3):225-36. Review.

PMID:
16112533
14.
15.

Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats.

Andersen ML, Santos EH, Seabra Mde L, da Silva AA, Tufik S.

J Ethnopharmacol. 2004 Apr;91(2-3):325-30.

PMID:
15120457
16.

Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS.

Karioti A, Fani E, Vincieri FF, Bilia AR.

J Pharm Biomed Anal. 2011 Jun 1;55(3):479-86. doi: 10.1016/j.jpba.2011.02.029. Epub 2011 Mar 2.

PMID:
21420820
17.

Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.

Inaba K, Murata K, Naruto S, Matsuda H.

J Nat Med. 2010 Apr;64(2):219-22. doi: 10.1007/s11418-010-0395-8. Epub 2010 Feb 23.

PMID:
20177800
18.

Clerodendrum serratum (L.) Moon. - a review on traditional uses, phytochemistry and pharmacological activities.

Patel JJ, Acharya SR, Acharya NS.

J Ethnopharmacol. 2014 Jun 11;154(2):268-85. doi: 10.1016/j.jep.2014.03.071. Epub 2014 Apr 13. Review.

PMID:
24727551
19.

Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice.

Mahomed IM, Ojewole JA.

Brain Res Bull. 2006 Mar 15;69(1):57-62. Epub 2005 Nov 15.

PMID:
16464685
20.

A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.

Ouitas NA, Heard CM.

Int J Pharm. 2009 Jul 6;376(1-2):63-8. doi: 10.1016/j.ijpharm.2009.04.017. Epub 2009 Apr 19.

PMID:
19383533
Items per page

Supplemental Content

Write to the Help Desk